Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Update on Safety Profiles of Vitamins B1, B6, and B12: A Narrative Review

Authors Calderon-Ospina CA, Nava-Mesa MO, Paez-Hurtado AM

Received 27 July 2020

Accepted for publication 4 September 2020

Published 22 December 2020 Volume 2020:16 Pages 1275—1288

DOI https://doi.org/10.2147/TCRM.S274122

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Garry Walsh


Carlos-Alberto Calderon-Ospina,1,* Mauricio Orlando Nava-Mesa,2,* Ana María Paez-Hurtado2

1Center for Research in Genetics and Genomics (CIGGUR), GENIUROS Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia; 2Neuroscience Research Group (NEUROS), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia

*These authors contributed equally to this work

Correspondence: Carlos-Alberto Calderon-Ospina
School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 No. 63C– 69, Bogota, DC, Colombia
Tel +571-2970200 Ext 3318
Fax +571-2818583
Email carlos.calderon@urosario.edu.co

Abstract: The neurotropic B vitamins B1 (thiamine), B6 (pyridoxine), and B12 (cobalamin) are essential for proper functioning of the nervous system. Deficiencies may induce neurological disorders like peripheral neuropathy (PN) and mainly occur in vulnerable populations (eg, elderly, diabetics, alcoholics). As epidemiologic cohort studies raised safety concerns about vitamin B6/B12 intake being potentially associated with increased risks of hip fracture (HF) and lung cancer (LC), we explored these aspects and performed comprehensive literature searches. However, we suggest not to neglect actual high-risk factors (eg, smoking in LC, higher age in HF) by focusing on individual nutrients, but to examine the complex interaction of numerous factors involved in disease development. Because it warrants continued consideration, we also provide an update on neurotoxicity associated with vitamin B6. We consider that neurological side effects due to vitamin B6 intake are rare and only occur with high daily doses and/or longer treatment duration. The benefit-risk ratio of high-dose treatment with neurotropic B vitamins in indications like PN is therefore considered advantageous, particularly if dosing recommendations are followed and serum levels monitored.

Keywords: neurotropic B vitamins, safety, thiamine, pyridoxine, cobalamin, neurotoxicity, hip fracture, lung cancer

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]